Mechanism of resistance to tyrosine kinase inhibitors - A case report and review

Dawnwin Joseph; Delcey Reachel Varghese; Raghuveer Prabhu; Anila K N

doi:10.5455/njppp.2017.7.0724615072017

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Case Report
Online Published: 26 Jul 2017

Natl J Physiol Pharm Pharmacol. 2017; 7(12): 1444-1446

doi: 10.5455/njppp.2017.7.0724615072017

Mechanism of resistance to tyrosine kinase inhibitors - A case report and review

Dawnwin Joseph, Delcey Reachel Varghese, Raghuveer Prabhu, Anila K N.

Abstract
This report aims to assess the viability of various challenging approaches such as tyrosine kinase inhibitors (TKIs) therapy, chemotherapy, and stem cell transplantation in patients with chronic myeloid leukemia (CML), especially for those in an advanced phase. Although standard treatments have been extremely effective in combating CML propagation and negating the disease symptoms along with an increased survival rate, these traditional treatment methods have experienced an increased failure rate due to TKI treatment resistance. A common mechanism that can be attributed to the increase in TKI resistance is the increasing mutations of the BCR-ABL 1 kinase domain. These mutations can be clearly observed in clinical trials. Currently, there are five BCR-ABL 1 kinase inhibitors that are approved for the safe treatment of CML. These are imatinib, dasatinib, nilotinib, bosutinib, and ponatinib. Mutational testing should be carried out on patients in such cases that show little response to traditional TKI therapy.In this report, we evaluate a patient who has been diagnosed with an accelerated phase CML and requires constant monitoring to tailor the treatment program to their requirements.

Key words: BCR-ABL; Chronic Myeloid Leukemia; Tyrosine Kinase Inhibitors; Imatinib

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Dawnwin Joseph Articles by Delcey Reachel Varghese Articles by Raghuveer Prabhu Articles by Anila K N
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Joseph D, Varghese DR, Prabhu R, N AK. Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. Natl J Physiol Pharm Pharmacol. 2017; 7(12): 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

Web Style

Joseph D, Varghese DR, Prabhu R, N AK. Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. https://www.njppp.com/?mno=271899 [Access: June 27, 2026]. doi:10.5455/njppp.2017.7.0724615072017

AMA (American Medical Association) Style

Joseph D, Varghese DR, Prabhu R, N AK. Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. Natl J Physiol Pharm Pharmacol. 2017; 7(12): 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

Vancouver/ICMJE Style

Joseph D, Varghese DR, Prabhu R, N AK. Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. Natl J Physiol Pharm Pharmacol. (2017), [cited June 27, 2026]; 7(12): 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

Harvard Style

Joseph, D., Varghese, . D. R., Prabhu, . R. & N, . A. K. (2017) Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. Natl J Physiol Pharm Pharmacol, 7 (12), 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

Turabian Style

Joseph, Dawnwin, Delcey Reachel Varghese, Raghuveer Prabhu, and Anila K N. 2017. Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. National Journal of Physiology, Pharmacy and Pharmacology, 7 (12), 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

Chicago Style

Joseph, Dawnwin, Delcey Reachel Varghese, Raghuveer Prabhu, and Anila K N. "Mechanism of resistance to tyrosine kinase inhibitors - A case report and review." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

MLA (The Modern Language Association) Style

Joseph, Dawnwin, Delcey Reachel Varghese, Raghuveer Prabhu, and Anila K N. "Mechanism of resistance to tyrosine kinase inhibitors - A case report and review." National Journal of Physiology, Pharmacy and Pharmacology 7.12 (2017), 1444-1446. Print. doi:10.5455/njppp.2017.7.0724615072017

APA (American Psychological Association) Style

Joseph, D., Varghese, . D. R., Prabhu, . R. & N, . A. K. (2017) Mechanism of resistance to tyrosine kinase inhibitors - A case report and review. National Journal of Physiology, Pharmacy and Pharmacology, 7 (12), 1444-1446. doi:10.5455/njppp.2017.7.0724615072017

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article